CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma

Chemoradiation is a common therapeutic regimen for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). However, not all patients benefit from chemotherapy, especially patients with low-risk characteristics. We aim to develop and validate a prognostic and predictive r...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Bolin, Yang, Kailin, Viswanathan, Vidya Sankar, Wang, Xiangxue, Lee, Jonathan, Stock, Sarah, Fu, Pingfu, Lu, Cheng, Koyfman, Shlomo, Lewis, James S., Madabhushi, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238543/
https://www.ncbi.nlm.nih.gov/pubmed/37268691
http://dx.doi.org/10.1038/s41698-023-00404-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238543/
https://www.ncbi.nlm.nih.gov/pubmed/37268691
http://dx.doi.org/10.1038/s41698-023-00404-w

Ejemplares similares